Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Net Margin: 2017-2025

Historic Net Margin for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -519.23%.

  • Arcus Biosciences' Net Margin fell 32756.00% to -519.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -180.42%, marking a year-over-year decrease of 7776.00%. This contributed to the annual value of -109.69% for FY2024, which is 15270.00% up from last year.
  • Arcus Biosciences' Net Margin amounted to -519.23% in Q3 2025, which was down 29.81% from -400.00% recorded in Q1 2025.
  • Over the past 5 years, Arcus Biosciences' Net Margin peaked at 78.83% during Q4 2021, and registered a low of -824.17% during Q3 2021.
  • In the last 3 years, Arcus Biosciences' Net Margin had a median value of -259.96% in 2023 and averaged -277.54%.
  • Examining YoY changes over the last 5 years, Arcus Biosciences' Net Margin showed a top increase of 177,268bps in 2021 and a maximum decrease of 82,700bps in 2021.
  • Over the past 5 years, Arcus Biosciences' Net Margin (Quarterly) stood at 78.83% in 2021, then tumbled by 27,589bps to -197.06% in 2022, then slumped by 6,423bps to -261.29% in 2023, then slumped by 10,025bps to -361.54% in 2024, then plummeted by 32,756bps to -519.23% in 2025.
  • Its last three reported values are -519.23% in Q3 2025, -400.00% for Q1 2025, and -361.54% during Q4 2024.